HM
ASMB icon

HealthCor Management’s Assembly Biosciences ASMB Stock Holding History

HealthCor Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-43,291
Closed -$8.54M – 60
2020
Q3 		$8.54M Buy
+43,291
New +$10.9M 0.34% 31
2015
Q4 		– Sell
-26,552
Closed -$3.05M – 45
2015
Q3 		$3.05M Sell
26,552
-15,562
-37% -$2.74M 0.17% 40
2015
Q2 		$9.73M Buy
42,114
+2,531
+6% +$488K 0.49% 37
2015
Q1 		$6.29M Buy
+39,583
New +$5.36M 0.3% 55

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

HealthCor Management's ASMB Position: Q4 2020 in Review

HealthCor Management sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 43,291 shares — an estimated $8.54M sold.

HealthCor Management first reported a position in ASMB in Q1 2015 and held it in 4 quarters. The position peaked at $9.73M in Q2 2015. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • HealthCor Management reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • HealthCor Management sold 43,291 Assembly Biosciences shares in Q4 2020, an estimated $8.54M.
  • HealthCor Management first reported a position in Assembly Biosciences in Q1 2015 and held it in 4 quarters.
  • HealthCor Management's Assembly Biosciences position peaked at $9.73M in Q2 2015.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on HealthCor Management's 13F filing for Q4 2020, filed 16 Feb 2021.